
GNSS
Genasys Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.435
Open
2.370
VWAP
2.37
Vol
91.62K
Mkt Cap
107.47M
Low
2.340
Amount
217.24K
EV/EBITDA(TTM)
--
Total Shares
44.60M
EV
119.06M
EV/OCF(TTM)
--
P/S(TTM)
3.51
Genasys Inc. is a global provider of protective communications solutions. The Company is engaged in the design, development, and commercialization of critical communications hardware and software solutions designed to alert, inform, and protect people. Its unified software platform receives information from a wide variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. The Company has two segments: Hardware and Software. Its solutions include Genasys Protect software platform, and Long-Range Acoustic Device (LRAD) products. Its Genasys Protect is a comprehensive portfolio of Protective Communications software and hardware systems serving federal governments and agencies; state and local governmental agencies, and education (SLED); and enterprise organizations. LRAD products broadcast audible voice messages with vocal clarity from close range out to 5,500 meters.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
18.10M
+161.11%
0.010
-107.14%
20.40M
+193.95%
0.015
-116.67%
20.10M
+198.18%
-0.020
-92.31%
Estimates Revision
The market is revising Downward the revenue expectations for Genasys Inc. (GNSS) for FY2025, with the revenue forecasts being adjusted by -0.68% over the past three months. During the same period, the stock price has changed by 47.83%.
Revenue Estimates for FY2025
Revise Downward

-0.68%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Up

+47.83%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast GNSS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNSS is 5.13 USD with a low forecast of 4.50 USD and a high forecast of 5.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.380
Low
4.50
Averages
5.13
High
5.75
Current: 2.380
Low
4.50
Averages
5.13
High
5.75
Northland
Outperform
to
NULL
downgrade
$6 -> $4
2025-05-14
Reason
Northland
Price Target
$6 -> $4
2025-05-14
downgrade
Outperform
to
NULL
Reason
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$4.75 → $5.5
2024-12-16
Reason
Ascendiant Capital
Edward Woo
Price Target
$4.75 → $5.5
2024-12-16
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Genasys Inc (GNSS.O) is 95.20, compared to its 5-year average forward P/E of 5.55. For a more detailed relative valuation and DCF analysis to assess Genasys Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
5.55
Current PE
95.20
Overvalued PE
90.09
Undervalued PE
-78.99
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
44.80
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
167.64
Undervalued EV/EBITDA
-78.05
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
2.59
Current PS
2.38
Overvalued PS
3.66
Undervalued PS
1.52
Financials
Annual
Quarterly
FY2025Q3
YoY :
+37.53%
9.86M
Total Revenue
FY2025Q3
YoY :
+10.52%
-5.93M
Operating Profit
FY2025Q3
YoY :
-2.92%
-6.49M
Net Income after Tax
FY2025Q3
YoY :
-6.67%
-0.14
EPS - Diluted
FY2025Q3
YoY :
-21.62%
-5.90M
Free Cash Flow
FY2025Q3
YoY :
-50.09%
26.35
Gross Profit Margin - %
FY2025Q3
YoY :
-43.23%
-35.96
FCF Margin - %
FY2025Q3
YoY :
-29.41%
-65.81
Net Margin - %
FY2025Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
2
307.3K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
2
307.3K
USD
Months
GNSS News & Events
Events Timeline
2025-11-06 (ET)
2025-11-06
10:08:54
Genasys Secures $1 Million Order for LRAD-RT
2025-10-13 (ET)
2025-10-13
09:25:17
Genasys Finalizes Acoustics Setup for the Alabama-Coushatta Tribe of Texas
2025-09-29 (ET)
2025-09-29
16:11:07
Genasys Receives $9.0 Million Order for LRAD Systems for CROWS
Sign Up For More Events
Sign Up For More Events
News
3.5
10-13NewsfilterGenasys Finalizes ACOUSTICS Installation and Commissioning for Alabama-Coushatta Tribe of Texas
6.0
09-29SeekingAlphaGenasys receives $9 million contract from the U.S. Army
9.5
08-14NASDAQ.COMGenasys Backlog Hits 61 Million in Q3
Sign Up For More News
People Also Watch

EUDA
EUDA Health Holdings Ltd
3.430
USD
+13.58%

MNSB
MainStreet Bancshares Inc
18.120
USD
-0.33%

QIPT
Quipt Home Medical Corp
2.470
USD
+7.86%

MCRB
Seres Therapeutics Inc
14.020
USD
+1.15%

SLDB
Solid Biosciences Inc
4.060
USD
-3.68%

HURC
Hurco Companies Inc
16.400
USD
-1.26%

ULBI
Ultralife Corp
6.750
USD
-1.75%

LCTX
Lineage Cell Therapeutics Inc
1.760
USD
+1.73%

CLYM
Climb Bio Inc
1.830
USD
-6.15%
FAQ
What is Genasys Inc (GNSS) stock price today?
The current price of GNSS is 2.38 USD — it has decreased -0.83 % in the last trading day.





